News | News By Subject | News by Disease News By Date | Search News

Biotechnology News Articles on Industry Topics

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Teva (TEVA) Finally Makes Mylan (MYL) Bid Official, With $40 Billion Offer For Biggest Takeover in 2015     4/21/2015
Pfizer (PFE) Snags FDA Breakthrough Therapy Tag for Xalkori     4/21/2015
Novartis AG (NVS) Taps Cancer Guru to Head Boston R&D Group That Specializes in Immuno-Oncology     4/21/2015
FDA, Genervon and ALS Blogger Battle Over Clinical Trial Interpretation     4/21/2015
CAR-T Cell Companies Juno Therapeutics (JUNO), Kite Pharma (KITE), and ZIOPHARM, Inc. Get Stock Jitters on Disappointing Novartis AG (NVS) Trial News     4/21/2015
In Largest Settlement Of Its Kind, Teva (TEVA) Will Pay $512 Million to Resolve Pay-to-Delay Case     4/21/2015
Cambridge's Dimension Therapeutics Nabs $65 Million     4/21/2015
Valeant (VRX) Rewards Top Execs $123 Million for Surpassing 2014 Goals     4/21/2015
Alnylam (ALNY)'s Phase II Study Confirms Effectiveness of RNAi Drugs     4/21/2015
Pfizer (PFE)'s Inotuzumab Ozogamicin Phase 3 Study Meets Primary Endpoint     4/21/2015
Allergan (AGN) Slashes 557 More Workers, After Former CEO’s $534M Payday     4/20/2015
Merck & Co. (MRK)'s Keytruda Effective Against Three Cancers     4/20/2015
American Airlines and GlaxoSmithKline (GSK) Job Cuts Provide Case Study of Local Economic Effects of Biopharma Jobs     4/20/2015
Tiny Curadev Wrangles a $555 Million Pact With Drug Giant Roche (RHHBY)     4/20/2015
Baxter International (BAX)'s Bleeding Disorder Drug Delivers 100% Success Rate in Late-Stage Study     4/20/2015

News from Around the Web
Even Dr. Oz's Boss Thinks He's "Full Of [It]"     4/21/2015
Three Bursting Biotech Stocks - One To Buy     4/21/2015
Kraft Removing Synthetic Colors From Iconic Mac & Cheese     4/21/2015
Milk Thistle May Stop Colorectal Cancer Stem Cells From Growing Tumors, University of Colorado Study     4/21/2015
Mushrooms Boost Immunity, University of Florida Study     4/21/2015
Chamomile Tea Linked To Lower Thyroid Cancer Risk, Oxford University Study     4/21/2015
Smoking May Boost Mom's Chances Of Having Twins, American Journal Of Human Biology     4/21/2015
Drugs Help MS Patients Create New Stem Cells To Replace Lost Brain Cells, Case Western Reserve University Study     4/21/2015
Stanford University, Harvard University Researchers To Share $500K Medical Prize     4/21/2015
First Infant MRI Study Finds Babies Feel Pain "Like Adults," Oxford University Study     4/21/2015
Queen Mary University Of London 's New Research Gives Clues As To Why Older People Get More Tendon Injuries     4/21/2015
Scientists To Share Real-Time Genetic Data On Deadly MERS, Ebola     4/21/2015
Is Bristol-Myers Squibb (BMY) About To Fall Apart?     4/20/2015
Long Term, Regular Aspirin Use May Reduce Cancer Risk, Harvard School of Public Health Study     4/20/2015
Remote Tribepeople Carry Antibiotic Resistance Genes, Washington University in St. Louis Study     4/20/2015

Press Releases
Brandon Capital Partners Dedicates $200 Million to Seeking the Next Big Thing     4/20/2015
NeuroVive Sets Up Shop in France and Intends to Hire for R&D     4/20/2015
Ampio Pharmaceuticals, Inc. (AMPE) Shares Decimated on Failed Trial Results     4/20/2015
KEYTRUDA (Pembrolizumab), Merck & Co. (MRK)’s Anti-PD-1 Therapy, Demonstrates Superior Survival, Progression Free Survival And Overall Response Rate Compared To Ipilimumab An Anti-CTLA-4 Therapy     4/20/2015
Full Data On Baxter International (BAX)’s Investigational Recombinant Treatment BAX 111 Supports Potential Role To Treat Von Willebrand Disease     4/20/2015
Cyclacel Pharmaceuticals, Inc. (CYCC)'s Second-Generation CDK2/9 Inhibitor, CYC065, Demonstrates Therapeutic Potential And Synergy With Other Anti-Cancer Compounds     4/20/2015
Onconova Therapeutics Inc. (ONTX) Submits Pivotal Clinical Trial Protocol For IV Rigosertib In Higher-Risk Myelodysplastic Syndromes To FDA And European Medicines Agency     4/20/2015
Data Presented At AACR Demonstrate Peregrine Pharmaceuticals, Inc. (PPHM)' Bavituximab Induces Immune Activation In PD-L1 Negative NSCLC Tumors     4/20/2015
Pembrolizumab, Merck & Co. (MRK)'s Investigational Anti PD-1 Therapy, Demonstrates Superior Survival, Progression Free Survival And Overall Response Rate Compared To Ipilimumab, An Anti-CTLA-4 Therapy, In A Phase 3 Study Of Patients With Advanced Melanoma     4/20/2015
Merz Neurosciences To Present Key Clinical Data At The Annual Meeting Of The American Academy of Neurology     4/20/2015
Bio Products Laboratory, Ltd. Announces Results From Phase III Registration Study Of Its Factor X Coagulation Product     4/20/2015
Anika Therapeutics (ANIK)' Cingal 13-02 Study Meets Primary Endpoint     4/20/2015
Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals, Inc.'s NP001 Potential Efficacy And Safety In ALS     4/20/2015
Nymox Pharmaceutical (NYMX) Announces New Prostate Cancer Clinical Trial Results     4/20/2015
Merck & Co. (MRK) Release: Treatment Of Advanced Non-Small Cell Lung Cancer (NSCLC) With Pembrolizumab Presented At AACR Annual Meeting And Published In The New England Journal of Medicine     4/20/2015
Immunocore Limited Announces Positive Clinical Trial Data For Novel First-in-Class Immunotherapy At AACR Annual Meeting 2015     4/20/2015
Halozyme Therapeutics, Inc. (HALO) Presents New Preclinical Data At AACR Annual Meeting, Announces Clinical Data Presentation At ASCO     4/20/2015
Kamada Ltd. (KMDA) Reports Additional Data From European Phase 2/3 Clinical Study Of Inhaled Alpha-1 Antitrypsin To Treat AAT Deficiency     4/20/2015
Pharmacyclics (PCYC) Release: IMBRUVICA (ibrutinib) Longer-Term Follow-Up Data Demonstrate Durable Responses, Including Complete Responses, In Patients With Chronic Lymphocytic Leukemia (CLL)     4/20/2015
Bristol-Myers Squibb (BMY) Release: First Randomized Study Evaluating Opdivo (Nivolumab)+Yervoy (Ipilimumab) Regimen Demonstrates Superior Efficacy Versus Yervoy Alone In Patients With Previously Untreated Advanced Melanoma     4/20/2015
Patients With Advanced Breast, Lung, Esophageal, And Colorectal Cancers Respond To Immunomedics, Inc. (IMMU)' Novel Antibody-Directed Chemotherapy After Failing Multiple Prior Standard Treatments     4/20/2015
Early Findings With KEYTRUDA (Pembrolizumab), Merck & Co. (MRK)’s Anti-PD-1 Therapy, In Patients With Advanced Pleural Mesothelioma Presented At American Association for Cancer Research Annual Meeting     4/20/2015
ChemoCentryx, Inc. (CCXI) Initiates Clinical Trial Of CCX872, Its Next-Generation, Orally Administered CCR2 Inhibitor, In Pancreatic Cancer     4/20/2015
Eli Lilly (LLY)'s Ixekizumab Met Primary Endpoint In A Phase 3 Study Investigating The Treatment Of Psoriatic Arthritis     4/20/2015
OncoCyte Corporation Announces Initial Data From Ongoing Clinical Study Of Collagen Type X As A Marker And Potential Diagnostic For Breast Cancer And Other Types Of Human Cancers     4/20/2015
PTC Therapeutics (PTCT) Phase 1 Data From Spinal Muscular Atrophy Program To Be Presented At The 2015 American Academy of Neurology Annual Meeting     4/20/2015
Actavis (ACT) Announces FDA Approval Of Expanded Label For Botox (Onabotulinumtoxina) For The Treatment Of Upper Limb Spasticity In Adults     4/20/2015
The Medicines Company (MDCO) Release: FDA Approves New Formulation Of MINOCIN (Minocycline) For Injection     4/20/2015
Pernix (PTX) Obtains Six Months U.S. Pediatric Exclusivity For Treximet     4/20/2015
Oasmia's Lead Cancer Product Paclical® Receives Market Approval In The Russian Federation     4/20/2015
Seattle Genetics, Inc. (SGEN) Release: FDA Accepts Supplemental BLA And Grants Priority Review For ADCETRIS (Brentuximab Vedotin) In The AETHERA Setting For The Post-Transplant Consolidation Treatment Of Hodgkin Lymphoma Patients At High Risk Of Relapse     4/20/2015
MediWound (MDWD) Initiates U.S. Phase 3 Trial With NexoBrid To Treat Severe Burns     4/20/2015
SAGE Therapeutics Announces First Patient Treated Under Phase 3 Expanded Access Protocol To Evaluate SAGE-547 In Patients With Super-Refractory Status Epilepticus     4/20/2015
Global Strategic Partners Merck KGaA (MKGAF.PK), Darmstadt, Germany, And Pfizer (PFE) nitiate Phase III Study With Avelumab* In Patients With Stage IIIb/IV Non-Small Cell Lung Cancer     4/20/2015
Pluristem Therapeutics (PSTI)'s Clinical Advisory Board Prepares Phase II Clinical Trials In Critical Limb Ischemia In Europe And Japan     4/20/2015
Otonomy, Inc. (OTIC) Completes Enrollment Of OTO-104 Multiple-Dose Safety Study In Meniere's Disease Patients     4/20/2015
Bionomics Limited (BNO.AX) Initiates Phase II Clinical Trial Of BNC210 For Treatment Of Anxiety     4/20/2015
DelMar Pharmaceuticals Presents Updated Clinical Data On Phase I/II Study Of VAL-083 In Refractory Glioblastoma Multiforme (GBM)     4/20/2015
Can-Fite BioPharma (CFBI) Applies For Orphan Drug Designation In Europe For CF102 In The Treatment Of Liver Cancer     4/20/2015
FDA Grants Fast Track Designation To Eiger Biopharma's Lonafarnib For Hepatitis Delta Virus (HDV) Infection     4/20/2015
cCam Biotherapeutics Announces Initiation Of Phase 1 Trial Of CM-24, A Novel Immune Checkpoint Inhibitor For Cancer Immunotherapy     4/20/2015
Cardio3 Biosciences Announces Infusion Of First Patient In NKG2D Phase I Trial With No Short Term Adverse Events     4/20/2015
Momenta Pharmaceuticals, Inc. (MNTA) Presents Key Glatopa (Glatiramer Acetate Injection) Data At American Academy of Neurology Annual Meeting     4/20/2015
Biogen (BIIB) Release: TECFIDERA (Dimethyl Fumarate) Data Reinforce Strong, Sustained Efficacy For Newly-Diagnosed MS Patients     4/20/2015
Rexahn Pharmaceuticals, Inc. (RNN) Identifies RX-3117 Biomarker & Presents Data At The 2015 AACR Annual Meeting     4/20/2015
Celldex (CLDX)'s Varlilumab Demonstrates Synergistic Anti-Tumor Activity With PD-1 Signaling Blockade In Preclinical Studies     4/20/2015
DelMar Pharmaceuticals Presents Positive Preclinical Data On Val-083 For Treatment Of Non-Small Cell Lung Cancer At AACR Annual Meeting     4/20/2015
TG Therapeutics, Inc. (MHA) Presents Pre-Clinical Data On IRAK4 Compounds At The AACR Annual Meeting     4/20/2015
Imugene Limited (IMU.AX) Release: HER-Vaxx Re-Formulation Shows Dramatic Ten-Fold Increase In Antibodies And Early Onset Of Response; Additional Milestone Met     4/20/2015
Blueprint Medicines Presents New Preclinical Data Demonstrating Significant Anti-Tumor Activity Of BLU-285 In Treatment-Resistant GIST And On Novel Cancer Drug Targets     4/20/2015
Oncolytics Biotech Inc. (ONC.TO) Collaborators Present REOLYSIN Preclinical Data At The 2015 AACR Annual Meeting     4/20/2015
NanoViricides, Inc. (NNVC.PK) Reports That Its Topical Anti-Herpes Treatment Dramatically Improves Clinical Symptoms In An Animal Model     4/20/2015
AVEO Oncology (AVEO) Announces Presentation Of AV-380 Preclinical Data In Cancer Associated Cachexia At 2015 Annual Meeting Of The AACR     4/20/2015
Pharmacyclics (PCYC) Release: Ibrutinib (IMBRUVICA) Improves OutcomesFor Pancreatic Ductal Adenocarcinoma In Mouse Models     4/20/2015
Acetylon Pharmaceuticals Announces Preclinical Anti-Cancer Activity Of Selective HDAC1/2 Inhibitors In Neuroblastoma And Acute Myeloid Leukemia     4/20/2015
DelMar Pharmaceuticals Presents Promising Preclinical Data On VAL-083's Potential To Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM)     4/20/2015
Peloton Therapeutics Presents Promising Data On First Inhibitor Of HIF-2a For Renal Cell Carcinoma At 2015 AACR Annual Meeting     4/20/2015
Ligand Pharmaceuticals Inc. (LGND) Partner TG Therapeutics, Inc. (MHA) Presents Positive Pre-Clinical Data On IRAK4 Compounds At The AACR Annual Meeting     4/20/2015
Tokai Pharmaceuticals (TKAI) Announces Preclinical Results From The University of Maryland Showing Galeterone And Analogs Inhibit Pancreatic Cancer Cell Growth     4/20/2015
Epizyme (EPZM) Presents Preclinical Research Providing Deeper Understanding Of Multiple Cancer Targets     4/20/2015
Results From The Sidney Kimmel Cancer Center At Thomas Jefferson University     4/20/2015
Case Western Reserve University Release: Drugs Stimulate Body’s Own Stem Cells To Replace The Brain Cells Lost In Multiple Sclerosis     4/20/2015
Portage Biotech's CPP Platform Delivers A Peptide Cargo Across Blood Brain Barrier     4/20/2015
Agilent Technologies Inc. (A) Recommends Stockholders Reject TRC Capital’s “Mini-Tender” Offer     4/20/2015
AbbVie (ABBV) Extends Exchange Offer To Acquire Pharmacyclics (PCYC)     4/20/2015
Intrexon Corporation Completes Acquisition Of Okanagan Specialty Fruits     4/20/2015
Qualyst, Inc. Transporter Solutions Announces New License Deal With Bioreliance On New Transporter Knock-out Products And Services     4/20/2015
Applied Genetic Technologies Corporation And 4D Molecular Therapeutics Sign Collaboration Agreement For Gene Therapy Vector Discovery And Product Development     4/20/2015
NeoStem, Inc. Announces Expanded Cell Therapy Manufacturing Relationship With Kite Pharma (KITE)     4/20/2015
TetraLogic Pharmaceuticals (TLOG) And Merck & Co. (MRK) To Collaborate On The Evaluation Of Birinapant In Combination With KEYTRUDA (Pembrolizumab) In Solid Tumors     4/20/2015
Cellular Biomedicine Group (CBMG) Engages Huntsworth Health To Build Global KOL Advocacy For Knee Osteoarthritis Stem Cell Rejoin(TM) Clinical Trials     4/20/2015
Horizon Discovery Group plc And Thermo Fisher Scientific (TMO) Sign Supply And Commercialization Agreement     4/20/2015
SillaJen Presents Data Demonstrating Pexa-Vec Synergy With Angiogenesis Inhibitors: A Collaboration With University of California, San Francisco (UCSF)     4/20/2015
PointCross Life Sciences And InterpretOmics Partner For Clinical And Genomic Biomarker Management For Drug Development     4/20/2015
TD2 And Navigating Cancer Partner To Bring Patient-Reported Outcomes To Clinical Trials Through A Cutting-Edge Mobile Application     4/20/2015
MYMETICS Corporation-Led Consortium Awarded €8.4 Million For Development Of Thermo Stable And Cold-Chain Independent Vaccines     4/20/2015
Centrillion Receives NIH Funding For Genomic Technology Development     4/20/2015
Neurotrope Receives Research Grant From The FRAXA Research Foundation To Fund Pre-Clinical Fragile X Syndrome Behavioral Studies     4/20/2015
Cytox Awarded Innovate UK Funding For Stratification Of Neurodegenerative Diseases     4/20/2015
BioPharmX Announces Violet Iodine is Now Available At The Vitamin Shoppe     4/20/2015
Immuron (ASX:IMC) Announces First USA Orders For Travelan     4/20/2015
Huntingdon Life Sciences And Harlan Laboratories, Inc. Announce The Launch Of The Shrntm Novel Hairless NOD.SCID Model At AACR 2015     4/20/2015
Lupin Ltd. (LUPN.BO) Launches Zaxine In Canada     4/20/2015
Bruker Corporation Launches New High-Performance Benchtop EPR System     4/20/2015
Pfizer (PFE) And Provectus Biopharmaceuticals Inc. Receive Patent Allowance For Use Of PV-10 In Combination With Systemic Immunotherapy Agents In Treatment Of Cancer     4/20/2015
Foamix Pharmaceuticals, Ltd. (FOMX) Announces Closing Of Its $69 Million Public Offering Of Ordinary Shares     4/20/2015
Aduro Biotech (ADRO) Announces Close Of IPO, Including Full Exercise Of Underwriters’ Option To Purchase Additional Shares, And Concurrent Private Placement     4/20/2015
Horizon Pharma (HZNP) Announces Proposed Private Offering Of Senior Notes And Intention To Enter Into New Term Loan Facility     4/20/2015
Reinnervate Limited Release: Alvetex 3D Cell Culture Platform Reaches New Heights With Project Aboard The International Space Station (ISS)     4/20/2015
Brüel and Kjaer Announces Innovative, High-Performance And Cost-Effective NMR Solutions For The Pharmaceutical Industry     4/20/2015
Cardinal Health (CAH) Agrees To Pay $26.8 Million To Settle Charges It Monopolized 25 Markets For The Sale Of Radiopharmaceuticals To Hospitals And Clinics, Says FTC     4/20/2015
PPD, Inc. (PPDI) Opens Central Lab In Shanghai, China     4/20/2015
Bruker Corporation Introduces Novel Solid-State NMR Probe With Ultra-High Spinning Frequency     4/20/2015
Agenus (AGEN) To Report First Quarter 2015 Financial Results On April 23, 2015; Conference Call To Follow     4/20/2015
INC Research, Inc. (INCR) Schedules First Quarter 2015 Earnings Call For Monday, April 27th     4/20/2015
PTC Therapeutics (PTCT) To Host Conference Call To Discuss First Quarter 2015 Financial Results     4/20/2015
Sinovac Biotech Ltd. (SVA) Reports Unaudited Fourth Quarter And Full Year 2014 Financial Results     4/20/2015
Sartorius AG Starts Off Fiscal 2015 With A Strong First Quarter     4/20/2015
Thoratec Corporation (THOR) Schedules First Quarter Conference Call, Webcast     4/20/2015
OpGen Appoints Industry Veterans Dr. Kevin Krenitsky As President And Timothy Dec As Interim Chief Financial Officer     4/20/2015
Vanda Pharmaceuticals, Inc. (VNDA) Announces The Appointment Of Chief Commercial Officer     4/20/2015
Professor Alain Marty Appointed Chief Science Officer At Carbios     4/20/2015
Purdue Pharma L.P. Names J. Alan Butcher Senior Vice President Of Licensing & Business Development     4/20/2015
BioClinica, Inc. Names Mukhtar Ahmed As eClinical President     4/20/2015
Ardelyx Inc. (ARDX) Appoints Dr. Annalisa Jenkins To Its Board Of Directors     4/20/2015
ChromaDex, Inc. Appoints Former GlaxoSmithKline (GSK) Executive, Jeff Baxter, To Its Board Of Directors     4/20/2015
Lysogene Appoints Annette Clancy As Chair Of The Board     4/20/2015
PharmaCyte Biotech (NVLX) Finalizes International Diabetes Consortium To Cure Diabetes     4/20/2015
Pharmacological Advancements In Neuroscience Drug Discovery & Pre-Clinical Studies For Fragile X Syndrome To Identify Drug Candidates For Autism Therapies Lead Biotech Sector Research     4/20/2015
PhytoTech Medical Limited (ASX:PYL) PYL-MMJ Investor Presentation     4/20/2015
Lucideon (Formerly Known As CERAM) Publishes White Paper On Controlled Release Fertilisers     4/20/2015
Mylan (MYL) Comments On Recent Media Speculation     4/20/2015
Axxess Pharma, Inc. Partner Roc Nation Sports To Promote Tapout Vitamins And Supplements Product Line On Fox Sports 1, Nationally Televised Throne Boxing Event On April 17, 2015     4/20/2015
The University City Science Center Release: "If Not for This Woman...” Science Center Seeking Nominations For Innovators Walk Of Fame     4/20/2015
Weighing Review Readers Name Mettler-Toledo (MTD) "Best Weighing Company"     4/20/2015
Maverix Biomics Demonstrates Leadership In Best Practices For Ngs Analysis At Bio-It World     4/20/2015
Meditope Biosciences Presents Data At AACRAnnual Meeting Validating Its SnAP Technology Platform     4/20/2015
Mission Therapeutics Ltd Presents At The Annual Meeting Of AACR The Identification Of Novel Inhibitors Of The UCHL1 Oncogene     4/20/2015
PerkinElmer, Inc. (PKI) To Present At Baird 2015 Growth Stock Conference     4/20/2015
SanBio Presents At Annual European Stroke Organisation Conference     4/20/2015
Theravance Biopharma To Present New Data Highlighting In Vitro Potency Of VIBATIV (Telavancin) Against Multidrug-Resistant Gram-Positive Bacteria, Including MRSA, At 2015 ECCMID Conference     4/20/2015
Virginia Bio Release: Thrive 2015 Conference To Focus On Bioscience Innovation     4/20/2015
NGM To Present New Data On NGM282 At The European Association For The Study Of The Liver International Liver Congress 2015     4/20/2015
Bruker Corporation Introduces Next-Generation GigaHertz NMR Technology At ENC 2015     4/20/2015
Epizyme (EPZM) To Present Updated Data From Ongoing Phase 1 Dose Escalation Trial Of EZH2 Inhibitor EPZ-6438 At International Conference On Malignant Lymphoma     4/20/2015
EBV-CTL Clinical Trial Data Presented By Atara Biotherapeutics' Collaborating Investigators At A Plenary Session At The AACR Annual Meeting 2015     4/20/2015
Ignyta (RXDX) Announces Multiple Presentations At The 2015 AACR Annual Meeting     4/20/2015
Foundation Medicine, Inc. (FMI) And Collaborators To Present New Data In 12 Oral And Poster Presentations At The AACR Annual Meeting     4/20/2015
Aurigene To Present Its NAMPT And IRAK-4 Inhibitors Programs At AACR 2015     4/20/2015
Sorrento Therapeutics, Inc. Announces Three Preclinical Poster Presentations On Cynviloq, Its Novel Antibody Drug Conjugate Linker Technology And C-Met/EGFR Bispecific ADC At The 106th Annual Meeting Of The AACR     4/20/2015
Genticel To Present Further Promising Pharmacology In-Vivo Results Of Its Phase 2 Immunotherapeutic Vaccine Candidate, GTL001 (Procervix), At AACR Annual Meeting 2015     4/20/2015
Protea Biosciences, Inc. Presents NEW Cancer Research Workflow At AACR     4/20/2015
Onxeo Release: Belinostat Abstracts For AACR 2015     4/20/2015
Infinity Pharmaceuticals Inc. (INFI) Reports Preclinical Data For Duvelisib In Combination With Venetoclax At The 2015 AACR Annual Meeting     4/20/2015
Atara Biotherapeutics (ATRA)' Collaborating Investigators' Abstract On T-Cell Therapy For EBV Lymphoma To Be Presented At A Clinical Trials Plenary Session At The American Association for Cancer Research Annual Meeting 2015 Is Now Available     4/20/2015
Argos Therapeutics, Inc. (ARGS) To Present Update On Pivotal Phase 3 ADAPT Clinical Trial During 2015 ASCO Annual Meeting     4/20/2015
Opexa Therapeutics (OPXA) Invited To Present Biomarker Data From NMO Patients At The American Academy of Neurology 2015 Annual Meeting     4/20/2015
Week In Review: Menarini And Lummy Announce Novel Drug In-Licensings For China     4/20/2015

Career Tips
Sucampo (SCMP) Looks to Add to "Scientific Core" As Global Reach Grows, Says HR     4/16/2015
8 Things That are Hurting Your Resume     4/16/2015
8 Ways to Increase Your Paycheck     4/16/2015
Flexion (FLXN) CEO Discusses Pipeline and Jobs     4/3/2015
What Employers Think When They See Your LinkedIn Profile     4/2/2015
Five Ways to Build Rapport With Your Interviewer     4/2/2015
Relypsa (RLYP) Hits the Big Leagues: New Hires in Almost Every Department     3/19/2015
Four Common Job Applicant Weaknesses     3/19/2015
Three Resume Secrets Professionals Swear By     3/19/2015
Booming PTC Therapeutics (PTCT) Means Job Openings     3/5/2015
Most Frequent Post-Job Interview Mistake     3/5/2015
Five Employer Concerns Every Job Applicant Must Address     3/5/2015
HR Exec Reveals In-Demand Jobs at MyoKardia     2/19/2015
Pfizer (PFE) Buy Means Jobs: Make Sure Your References Are an Asset     2/19/2015
7 Job Search Sins     2/19/2015

Other News Sources
//-->